O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.
Cancer
; 118(18): 4545-54, 2012 Sep 15.
Article
en En
| MEDLINE
| ID: mdl-22359215
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Encefálicas
/
Regiones Promotoras Genéticas
/
Glioblastoma
/
Metilación de ADN
/
O(6)-Metilguanina-ADN Metiltransferasa
Tipo de estudio:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Cancer
Año:
2012
Tipo del documento:
Article
País de afiliación:
Francia